Amy Lynch


Ms. Lynch joined TCR² in 2015 as Associate Director of Operations and Project Management. She brings over 10 years of biopharmaceutical industry experience across a range of operational roles. Prior to joining TCR², Ms. Lynch was the Associate Director of Operations and Investor Relations/Project Management at Catabasis Pharmaceuticals (NASDAQ: CATB), a rare diseases company where she built out the company infrastructure and helped implement cross-functional areas including IT, HR, facilities, project management and investor relations as one of its first employees. Prior to Catabasis, she was the Biological Services Manager at Sirtris Pharmaceuticals (acquired by GlaxoSmithKline). Ms. Lynch earned her BS in Biochemistry, Cellular, Molecular Biology from Connecticut College.